Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 16 December 2025

Rheinmetall Stock Price Today (16 December 2025): RHM Shares Slide on Ukraine Peace-Talk Momentum, While Analysts Keep High Targets

Rheinmetall Stock Price Today (16 December 2025): RHM Shares Slide on Ukraine Peace-Talk Momentum, While Analysts Keep High Targets

Frankfurt, Dec. 16, 2025 — Rheinmetall shares are under pressure today as investors react to fresh optimism around Ukraine peace talks, a headline theme that has weighed on European defence stocks across the board. Even with multiple positive corporate developments in the background—including progress on a major German tank project and a new counter-drone showcase in Finland—the market’s focus on geopolitics is dominating price action in the short term. Reuters+2finanzen.net+2 Rheinmetall stock price today: the latest level and what it means Rheinmetall (traded in Germany under RHM / RHMG.DE) was trading around €1,500 per share on Tuesday, down roughly 4–5% versus the prior close, putting the company
16 December 2025
··
Barclays Share Price Today (16 December 2025): BARC Slips as UK Rate-Cut Bets Grow, Buyback Update in Focus

Barclays Share Price Today (16 December 2025): BARC Slips as UK Rate-Cut Bets Grow, Buyback Update in Focus

Barclays shares were slightly lower in Tuesday trading as investors digested fresh UK labour-market data, shifting Bank of England (BoE) expectations, and the latest update on the lender’s ongoing share buyback programme. As of the latest delayed quote available during the session, Barclays (LSE: BARC) was trading at 451.90p, down 2.35p (-0.52%) on the day. The stock opened at 453.00p, traded as high as 457.45p, and touched a low of 451.75p. The previous close was 454.25p. That left the bank’s equity near the top end of its recent trading range—still close to its 52‑week high area (around 457p) after a strong 2025 run, but easing as the market repriced the near-term
16 December 2025
··
Intel Stock News Today (Dec. 16, 2025): SambaNova Deal Buzz, Washington Power Moves, and Wall Street Forecasts for INTC

Intel Stock News Today (Dec. 16, 2025): SambaNova Deal Buzz, Washington Power Moves, and Wall Street Forecasts for INTC

Intel Corporation (Nasdaq: INTC) is back in the middle of the market’s favorite kind of drama: the kind where strategy, politics, AI ambition, and corporate governance all collide in one ticker symbol. As of Tuesday, Dec. 16, 2025, Intel shares were trading around $37.51, down about 0.8% from the prior close (prices move quickly, but that’s the snapshot at the latest reported trade time). What’s driving attention today isn’t a single headline—it’s a stack of them. Investors are weighing: Below is the full roundup of the major Intel stock news, forecasts, and analysis threads dominating coverage on 16.12.2025. What’s moving
16 December 2025
·
Grab Holdings Limited (NASDAQ: GRAB) Stock: Latest News, Analyst Forecasts, and Outlook (December 16, 2025)

Grab Holdings Limited (NASDAQ: GRAB) Stock: Latest News, Analyst Forecasts, and Outlook (December 16, 2025)

Grab Holdings Limited (NASDAQ: GRAB) is trading in a familiar battleground for 2025: the $5 area, where short-term sentiment (risk-off tape, profit-taking, and headline-driven swings) keeps colliding with a longer-running fundamental story of improving profitability and cash generation. As of pre-market trading on Tuesday, December 16, 2025, GRAB hovered around $5.00, after closing Monday, December 15 at about $5.01, down roughly 2.7% on the day with elevated volume. StockAnalysis Below is a comprehensive look at the current news flow, the latest company guidance, and where Wall Street forecasts and debate stand as of 16.12.2025. GRAB stock price today: where shares
16 December 2025
·
BigBear.ai (BBAI) Stock News Today (Dec. 16, 2025): Share Vote Catalyst, Ask Sage Deal Timeline, Analyst Forecasts, and What Investors Are Watching

BigBear.ai (BBAI) Stock News Today (Dec. 16, 2025): Share Vote Catalyst, Ask Sage Deal Timeline, Analyst Forecasts, and What Investors Are Watching

BigBear.ai Holdings, Inc. (NYSE: BBAI) is having the kind of December that high‑beta “AI + national security” stocks tend to have: huge volume, sharp moves, and investors trying to decide whether they’re buying a real long‑run platform story… or renting a very expensive rollercoaster for the afternoon. As of the latest completed U.S. session (Monday, Dec. 15, 2025), BBAI closed at $5.97 on roughly 127.7M shares traded—an eye-catching volume figure for a company of this size. Nasdaq Below is a comprehensive, as-of Dec. 16, 2025 roundup of the key news, forecasts, and analyses driving BigBear.ai stock right now—plus the next
16 December 2025
·
BitMine Immersion Technologies (BMNR) Stock Today: Cathie Wood Buys the Dip as BitMine Pushes Toward 5% of Ethereum Supply

BitMine Immersion Technologies (BMNR) Stock Today: Cathie Wood Buys the Dip as BitMine Pushes Toward 5% of Ethereum Supply

December 16, 2025 — BitMine Immersion Technologies, Inc. (NYSE American: BMNR) is back in the spotlight after a sharp selloff in crypto-linked equities collided with two very “BitMine” storylines: aggressive Ethereum accumulation and big-ticket institutional buying. On one side, BMNR stock slid hard alongside a broader risk-off move in digital assets. On the other, Cathie Wood’s ARK Invest stepped in with a sizable purchase, and BitMine itself reported that its Ethereum position has grown into a jaw-dropping chunk of total supply—now framing the company less like a traditional miner and more like an Ethereum treasury vehicle with a public-market wrapper.
16 December 2025
···
Rivian Stock (RIVN) Today: Autonomy & AI Day Fueled a Rally—Now Analysts Debate the 2026 Roadmap

Rivian Stock (RIVN) Today: Autonomy & AI Day Fueled a Rally—Now Analysts Debate the 2026 Roadmap

December 16, 2025 — Rivian Automotive, Inc. (NASDAQ: RIVN) has become one of the EV market’s most closely watched “story stocks” again—this time for something bigger than quarterly deliveries: a hard pivot into vertically integrated autonomy, custom silicon, and recurring software revenue. Rivian shares are hovering near the high teens after a burst of volatility tied to the company’s inaugural Autonomy & AI Day and the analyst reaction that followed. The stock closed at $18.70 on December 15, according to MarketBeat’s market data. MarketBeat What changed? Rivian didn’t just demo features—it laid out a strategy that looks more like a
16 December 2025
···
Plug Power Stock (NASDAQ: PLUG) Today: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 16, 2025

Plug Power Stock (NASDAQ: PLUG) Today: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 16, 2025

Plug Power Inc. (NASDAQ: PLUG) is back in the spotlight on December 16, 2025, as investors weigh a familiar tug-of-war: improving liquidity and commercial momentum on one side, and persistent losses, dilution risk, and an uncertain hydrogen market on the other. After closing Monday, Dec. 15, at about $2.22, Plug’s shares remain deep in “high-volatility territory,” sitting well below the stock’s $4.58 52-week high (reached in early October) and above its $0.69 52-week low. MarketBeat+2MarketWatch+2 Below is a comprehensive, publication-ready look at what’s driving Plug Power stock, the latest corporate developments and filings, and where Wall Street forecasts stand as
16 December 2025
··
CoreWeave Stock Slide Sparks Fresh AI Bubble Fears as Debt, Data Center Delays, and Chip Depreciation Take Center Stage

CoreWeave Stock Slide Sparks Fresh AI Bubble Fears as Debt, Data Center Delays, and Chip Depreciation Take Center Stage

On December 16, 2025, CoreWeave’s sharp selloff became a lightning rod for a broader market debate: is the AI infrastructure boom entering its most fragile phase, where execution hiccups and financing costs matter more than hype? New reporting and market commentary today highlights a mix of catalysts—construction delays at a key Texas data center tied to OpenAI, worries about debt-heavy growth, and a rising chorus of skeptics questioning whether the economics of renting cutting-edge Nvidia GPUs can hold up as hardware ages fast and capital gets more expensive. The Wall Street Journal+1 CoreWeave isn’t alone. The same anxiety has pressured
16 December 2025
······
Ondas Holdings Inc Stock (ONDS) Slides on Dec. 16, 2025 as Stifel Initiates Coverage, Investors Weigh Debt Exchange and Defense-Drone Growth

Ondas Holdings Inc Stock (ONDS) Slides on Dec. 16, 2025 as Stifel Initiates Coverage, Investors Weigh Debt Exchange and Defense-Drone Growth

Ondas Holdings Inc. stock (NASDAQ: ONDS) is under pressure on Tuesday, December 16, 2025, with shares recently trading around $7.69, down about 12% from the prior close—an abrupt reminder that defense-tech “story stocks” can move fast in both directions. The timing is especially notable: the latest pullback comes as Stifel initiated coverage with a Buy rating and a $13 price target, while traders also digest a newly disclosed exchange tied to Ondas Autonomous Systems (OAS) that could bring additional shares into the market and trigger a sizable one-time, non-cash accounting charge in Q4. Investing.com India+1 Below is what’s driving the
16 December 2025
·
NVIDIA Stock (NVDA) News and Forecasts for Dec. 16, 2025: Nemotron 3, SchedMD Deal, and China H200 Exports Take Center Stage

NVIDIA Stock (NVDA) News and Forecasts for Dec. 16, 2025: Nemotron 3, SchedMD Deal, and China H200 Exports Take Center Stage

NVIDIA Corporation (NASDAQ: NVDA) stock is hovering around $176 in early Tuesday trading (last trade recorded at $176.29 as of 11:45 UTC on December 16, 2025), modestly higher versus the prior close. That price level matters because it frames the story investors are wrestling with right now: NVDA isn’t moving on a single headline. It’s moving on a stack—open-source AI models, deeper control of AI “plumbing” inside data centers, and a high-stakes shift in U.S.-China chip export policy. If you’re trying to understand what could drive Nvidia’s next leg up—or down—this is the set of narratives shaping the stock as
16 December 2025
··
American Airlines Stock (AAL) News Today: S&P EETC Upgrade, UBS “Buy” Call, and Holiday Travel Catalyst in Focus (Dec. 16, 2025)

American Airlines Stock (AAL) News Today: S&P EETC Upgrade, UBS “Buy” Call, and Holiday Travel Catalyst in Focus (Dec. 16, 2025)

American Airlines Group Inc. (NASDAQ: AAL) is back on investors’ radar on Tuesday, December 16, 2025, as the carrier heads into a high-stakes holiday travel stretch while fresh updates from credit markets and Wall Street analysts reshape the near-term narrative. After closing Monday, Dec. 15 at $15.33 (+2.47%)—with a session range of roughly $14.86 to $15.35 on heavy volume—AAL entered Tuesday’s session with momentum and plenty of headline gravity. Investing.com Below is a full, up-to-date roundup of the current news, forecasts, and market analysis shaping American Airlines stock as of 16.12.2025—and what investors are watching next. AAL stock snapshot: what
16 December 2025
·
Tesla Stock (TSLA) News Today: Robotaxi Tests Fuel Rally, But Wall Street Forecasts Split Wide on Dec. 16, 2025

Tesla Stock (TSLA) News Today: Robotaxi Tests Fuel Rally, But Wall Street Forecasts Split Wide on Dec. 16, 2025

Tesla, Inc. (NASDAQ: TSLA) is trading around $475 on December 16, 2025, keeping the stock near the upper end of its recent range after Monday’s sharp move. As of 11:41 UTC, TSLA was $475.31, up about 3.5% versus the prior close. Investing.com What’s driving the attention isn’t a new vehicle launch or a quarterly earnings surprise—it’s the same narrative that has increasingly dominated Tesla’s market value in 2025: autonomy. A fresh milestone in Tesla’s robotaxi testing has energized bulls, while skeptics point to valuation, regulatory scrutiny, and the simple fact that Tesla still makes most of its money the old-fashioned
16 December 2025
··
Uber Stock (UBER) Slides on FTC Uber One Lawsuit as Analysts Hold Bullish Targets — What to Know on Dec. 16, 2025

Uber Stock (UBER) Slides on FTC Uber One Lawsuit as Analysts Hold Bullish Targets — What to Know on Dec. 16, 2025

Uber Technologies, Inc. (NYSE: UBER) stock traded lower on Tuesday, December 16, 2025, as investors digested an escalated regulatory challenge tied to the company’s Uber One subscription program—while Wall Street’s broader outlook on the rideshare and delivery leader stayed notably constructive. As of 11:22 UTC on Dec. 16, Uber shares were at $81.86, down about 3.84% from the prior close. The day’s move highlights a familiar pattern for Uber stock: near-term volatility driven by legal and regulatory headlines, set against a longer-running debate about whether Uber’s platform strategy—spanning Mobility, Delivery, and an expanding set of partnerships—can compound profitably into 2026
16 December 2025
·
Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb Company (NYSE: BMY) is back in the spotlight on December 16, 2025, with the stock trading around $54.29, up roughly 3.6% on the session as optimism builds around Wall Street upgrades, a newly announced dividend increase, and a steady drumbeat of pipeline and regulatory updates heading into 2026. Smartkarma While BMY has spent much of the past year wrestling with familiar big-pharma headwinds—generic erosion in legacy products and a looming “patent cliff” narrative—the last several weeks have looked more like a sentiment reset than a victory lap. One analysis notes a ~16% move over the last 30 days
16 December 2025
···
Terns Pharmaceuticals (TERN) Stock Today: Latest News, Analyst Forecasts, and What to Watch (December 16, 2025)

Terns Pharmaceuticals (TERN) Stock Today: Latest News, Analyst Forecasts, and What to Watch (December 16, 2025)

Terns Pharmaceuticals, Inc. (NASDAQ: TERN) is still living inside one of the more dramatic biotech story arcs of 2025: eye-popping clinical data, followed immediately by a massive equity raise, followed by a flurry of analyst price-target resets. As of Tuesday, December 16, 2025, TERN shares were trading around $44. That price level matters because it sits right on top of the two big forces investors have been digesting all month: Below is a complete, publication-ready roundup of the current news, forecasts, and market analysis shaping Terns Pharmaceuticals stock as of 16.12.2025, plus the catalysts that could drive the next move.
16 December 2025
··
Venus Concept Inc. (NASDAQ: VERO) Stock: Latest News, Catalysts, and Forecasts as of December 16, 2025

Venus Concept Inc. (NASDAQ: VERO) Stock: Latest News, Catalysts, and Forecasts as of December 16, 2025

Venus Concept Inc. stock (NASDAQ: VERO) is back on traders’ radar in mid-December 2025—less because it’s a calm, steadily compounding story (it isn’t), and more because the company has stacked multiple high-impact catalysts and balance-sheet developments into a tight window. As of the Dec. 15 close, VERO finished around $1.67, down roughly 10.7% on the day, and early Dec. 16 pre-market quotes indicated a sharp rebound attempt near $2.16—a reminder that this remains a thinly traded micro-cap where price can gap hard in either direction. StockAnalysis Below is a full, publication-ready breakdown of the latest company news, what recent filings
16 December 2025
·
Inspire Veterinary Partners (IVP) Stock News Today: Nasdaq Delisting Risk, Dilution Signals, and 2026 Catalysts (Dec. 16, 2025)

Inspire Veterinary Partners (IVP) Stock News Today: Nasdaq Delisting Risk, Dilution Signals, and 2026 Catalysts (Dec. 16, 2025)

December 16, 2025 — Inspire Veterinary Partners, Inc. (NASDAQ: IVP) is once again on traders’ radar, but not for the comforting reasons investors typically like in a healthcare-services name. The stock is trading around $0.05 per share in early Tuesday action, after a stretch of extreme volatility driven by Nasdaq listing risk, capital-structure changes, and a growing conversation around potential dilution. Investing.com Below is a complete, up-to-date rundown of the latest IVP stock news, filings, forecasts, and analysis as of December 16, 2025, plus what to watch next. IVP stock price action on December 16, 2025: microcap volatility on full
16 December 2025
·
Pfizer Stock (PFE) Today, Dec. 16, 2025: 2026 Guidance Call Looms as Analysts Weigh Dividend, Deal Flow, and Policy Risks

Pfizer Stock (PFE) Today, Dec. 16, 2025: 2026 Guidance Call Looms as Analysts Weigh Dividend, Deal Flow, and Policy Risks

Pfizer Inc. (NYSE: PFE) heads into Tuesday, December 16, 2025 with a familiar “big pharma” cocktail of catalysts: an imminent guidance event, a high dividend yield, fresh dealmaking in hot therapeutic areas (immunology and obesity), and a regulatory backdrop that can flip sentiment faster than a lab centrifuge. Shares closed Monday at $26.43, up 2.24%, extending a four-session winning streak, according to MarketWatch. MarketWatch On the data side, Pfizer’s own calendar is the center of gravity: the company is scheduled to host an 8:00 a.m. EST analyst call today to provide full-year 2026 financial guidance. Pfizer+1 Below is what’s driving
16 December 2025
···
Nektar Therapeutics Stock (NKTR) Surges Into a Major Catalyst: What to Know Ahead of Today’s REZOLVE-AA Data

Nektar Therapeutics Stock (NKTR) Surges Into a Major Catalyst: What to Know Ahead of Today’s REZOLVE-AA Data

Nektar Therapeutics (NASDAQ: NKTR) is in classic “biotech catalyst mode” on December 16, 2025—the kind of day when a single dataset can rewrite a stock chart in minutes. Shares climbed in pre-market and overnight trading as investors positioned for topline results from the 36-week induction period of Nektar’s Phase 2b REZOLVE-AA study in severe-to-very-severe alopecia areata, featuring its lead investigational candidate rezpegaldesleukin (REZPEG / NKTR-358). The company scheduled an investor call and webcast for 8:00 a.m. ET, and said the topline results would be released in a morning press release before the webcast. PR Newswire+1 By the numbers, NKTR closed
16 December 2025
··
1 … 746 747 748 749 750 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop